Elisa. Because they were inherited and when dividends arrive, it’s nice to remember great-aunt.
Otherwise, everything goes if a price is agreed upon, except for individually purchased shares (these can be used to attend company meetings, there are ten different kinds).
Perhaps the most tightly held are Fondia shares.
I’ve also held UPM as a dividend machine for a long time and won’t sell easily. I like the company’s energy self-sufficiency and its overall investment in new areas.
Let’s add the following to my own list from the neighboring country: Getinge and AstraZeneca. Both have also been held for over 10 years. The offerings of pharmaceutical companies and healthcare providers on the Helsinki stock exchange are so limited that I’ve sought these from Sweden.
I’ve held Remedy since the IPO and plan to keep holding and increasing my stake until maybe someday a bigger player buys out the entire studio.
I also intend to hold a small slice of Ethereum for the long term. Additionally, SP500 and other index ETFs will, of course, remain in the portfolio “forever.”
A man would sooner eat his words than sell Nio.
Xbrane Biopharma 
is and stays
All stocks in my portfolio have been bought with the intention of owning them long-term. Four picks could be Harvia (reasons well-justified previously), Orthex (growing, profitable company with good management and a sufficiently “boring” sector), Leaddesk, and Efecte (we are at the beginning of the growth path, and according to the SaaS business model, profit recovery is expected only in the future, so why wouldn’t I wait at least until then?)
However, a few are in the so-called “watch list” category, meaning with their current performance, they won’t stay in the portfolio, but a turn for the better must come for me to stay on board. This has, of course, been the thesis when investing. These are Rovio and Fondia.
No stock/company is such that I wouldn’t give them up under any circumstances. However, I don’t rush into decisions based on fluctuating stock prices or changes in valuation levels; rather, a turn for the worse must happen within the company itself for me to sell the shares.
Additionally, I invest to live, not the other way around. So, if something unexpected or groundbreaking were to happen in my civilian life that could be alleviated with money, I would sell my stocks. This, however, does not include acquiring a cottage/car/boat/foreign trip, but rather, for example, an illness or something similar.
I wouldn’t mind if Marimekko still tenbagged from here. My purchase price was €3, and next summer will mark 20 years of holding.
It was a Lynchian purchase back in the day when the streets seemed to be full of Marimekko.
Strong performance during Kirsti Paakkanen’s time, then stagnation during Mika Ihamuotila’s time, and then again incredibly strong performance during Tiina Alahuhta-Kasko’s time.
It just shows how decisively the CEO impacts things.
Unfortunately, I lightened my position by a third during that period of stagnation. Even that would have 5-bagged from the selling price if I had been patient.
Yes, it seems Fortum is my choice.
That extra “summer holiday money” that
appears in the spring is nice.
Of course, there are others. But if I had to pick one above all others.
Kamux will probably be my forever stock, as I first bought it in early 2020 when it seemed “too good to be true,” but its success has remained true until now, even though the short-term share price might suggest otherwise (at least the price won’t get too high, so there’s no compelling urge to sell 
).
It’s the stock I’ve added to the most, with well over 10 additions, and only one small reduction conveniently before the stock market crash, after which I’ve refilled three times, and its weight in my portfolio has again approached the 20% limit, which was why I made the reduction then. RIP if it starts rising again 
. The average price is probably still around 10 euros.
I don’t intend to hold any “safe” cyclical popular stocks with a large weighting, even though Fortum and Sampo are among my top 10 largest holdings for dividends.
My entire portfolio is actually built for the long game. So, to answer the question:
-Fortum
-Sampo
-Nordea
-Harvia
-Mocorp
-Valmet
-UPM
-Dovre
-Incap
-Kemira
-Titanium
-OMASP (shorter game)
-Inderes (maybe HODL, maybe not)
-Saab AB (I’m not entirely sure about this one. We’ll see about the HX project at least)
-Bittium (the end of the year will decide)
With a portfolio like this, at least dividends will rain down commendably, even if capital appreciation is sometimes smaller.
I have a similar plan to many of the others who have written above. You never know what the future holds, but for the most part, my portfolio will consist of long-term investments. The focus is strictly on decades, not just a few years.
Several others are on my watchlist, waiting for prices to drop below safety margins. I’m really bad at spotting potential growth rockets, so the idea is to let the companies I choose do most of the work, and I’ll focus on collecting dividends. For me, investing is mostly about waiting until a quality dividend payer falls into the discount basket. Unnecessary trading just eats into long-term returns.
Tokmanni
My first stock purchase, and the intention is to hold it for a long time. It seems that Tokmanni might be facing some kind of corporate restructuring in the coming years, but hopefully Tokmanni will be in the driver’s seat. I also admit that there’s some kind of collecting and fan phenomenon behind this. And as the wise have said, you shouldn’t fall in love with a stock.
PYN Elite fund. It’s not a stock, so it’s off-topic.
My belief in the market and the fund is strong, and fortunately, redemptions are a minimum one-month process and require a bit of effort, so I’m less likely to sell during weak moments, unlike with stocks. It’s also nice that the ownership isn’t under daily scrutiny in my Nordnet portfolio; it just grinds along in the background, allowing me to make both foolish and less foolish moves in my Nordnet portfolio.
Of course, if the fund’s story fundamentally changes, the sell button will be pressed.
Let’s look back. Here are my longest-held investments (4 years) that are still in my portfolio.
Of course, the positions I created years ago were small relative to the current state of the portfolio. These are also not the best investments in terms of total return, and at least some are classic slow-growers. On the other hand, they are worry-free, cash-flow-generating investments, which is why they get to stay in the portfolio. Those that have yielded over 100% are HASI, Novo, VFC, ROST, UPM, AFL.
ABB
Aflac (AFL)
Coca-Cola
Deutsche Telecom
Hannon Armstrong (HASI)
Kimco Realty
Kone
Novo Nordisk
Pfizer
Realty Income
Ross Stores (ROST)
Sampo
Tele2
Telenor
Telia
UPM
VF Corp (VFC)
On the other hand, my more recent investments are the best in terms of total return in euros: QT, Talenom, Revenio, all of which have multiplied. If there are no surprises, these will remain in the portfolio for a long time.
Edit: The portfolio contains over 40 companies, the largest being Qt (12%) and Talenom (6%).
Edit2: Kone has also yielded 100%, which I had forgotten. The best example of what a stable and worry-free investment target looks like.
My Holdings: (Perpetual Hold)
(At least a long-term hold)
Harvia: I want to be part of a Finnish success story. I enjoy taking a sauna and appreciating Harvia at the same time.
Metso:Outotec: As a company and an industry, I believe it will perform at least well in the future. (What kind of situation would it be if aggregates or metals were not needed?)
Spinnova: If it succeeds, it’s a big win; if not, it doesn’t really have a major impact on my portfolio’s success.
Finnair: Safe and high-quality wings are always needed.
++ Vaisala: Here too, the industry and the strong expertise of Vaisala employees inspire confidence, BUT I traded this out during the summer/autumn when I needed capital, and the price was a bit daunting. I’ll buy back if I can get quality at a reasonable price again 
First and foremost, it’s good to remember not to fall in love with stocks. The second point to note is that a business’s competitive advantage should be so strong that even with mediocre management, things don’t go south. I’m not entirely convinced that some gaming companies, etc., fall into this category.
The largest investment in my portfolio, Bufab, could meet these criteria. Its competitive advantage strengthens moment by moment as the business grows. It’s an extremely simple business, yet very difficult for competitors.
Both the “Tikka” and “Kansansalkku” portfolios are intended for long-term holding. Each will have 3 more stock selections.
In addition to these, there is a third portfolio with long-term holdings, including a few funds:
The plan is to add more of these periodically, depending on the price and available cash.
In principle, I follow (and sell if necessary) all stocks, but at least these are held for a remarkably long time:
Fortum. I got in during the COVID crash at an average cost of 12.xx. A stable earner that provides suitable diversification to the portfolio. Since I got in cheaply, the dividends are significant and roll in consistently year after year. Uniper brings good earnings growth potential.
Nordea. This also offers a bit of diversification into a value crawler, which I don’t have a strong opinion on. The position is so small that I won’t be selling it easily. A good dividend payer.
Wärtsilä. Also acquired during the COVID dip. Currently, the outlook is not the best, but I got in at just over 6 euros, so I’ll let the dividends run. I believe the company will be in good shape even after the next 10+ years.
Sanoma. I must admit that this is perhaps the most boring stock in my portfolio. It pays an okay dividend, and the media business brings in nice cash flow. In addition, the learning business promises a good future, and it has quite decent growth prospects. The position size is small, and I don’t intend to add more. Let it molder at the bottom of the portfolio.
Apparently, a few things unite these “forever holds”:
The portfolio contains 20 stocks and 9 funds. The proportion of funds is significantly smaller, but the intention is to reverse the situation over time. This includes the idea of selling certain stocks and, on the other hand, focusing new investments on funds. These funds are then intended to be used starting 30 years from now. All stocks are under constant observation, but in my estimation, the probability of owning the following stocks in 10 years is higher compared to others in my portfolio:
Sampo, Kesko, Tokmanni, Qt, Fortum, Harvia, Cibus.
Elisa I inherited these from my great-aunt (déjà vu?). She said, “don’t you dare sell these.” So I won’t. Dividends are okay.
Rheinmetall I am a pacifist and abhor institutional violence, but I want Europe to remain in roughly its current format. I believe that so many others want this too, that it will remain profitable. I plan to hold until all the nations of the world walk hand in hand, as friendly and gentle to each other as the Inderes forum members.
Hyzon Following the crowd until 2025.
A little bit of mixed uranium. In the medium term, I believe this is needed to save the world.
Edit:
Also small amounts of some “speculative” bio/pharma companies, with which I am prepared to wait years for something to happen.
Marimekko I don’t think I could bring myself to part with this. Secretly, I hope it first ten-bags, and then Kering, LVMH, Fast Retailing or someone else forcibly buys it from me, doubling the price even further. While waiting for that, it doesn’t feel bad to own.
Ready to change my mind on everything according to changing circumstances. And some have a earmarked portion that is intended to be sold if it rises sufficiently.